I think that Leo and Dr.M are less interested in s
Post# of 72440
My understanding with Prurisol is that it will be worth much more after completing the next FDA trials then it would after a proof of concept trial which was purely for raising money.
The Aspire deal is nice, but still it is not a real investent in CTIX and most know that. As long as Aspire sells their shares following CTIX requesting money it is not an investment its a flip. I'd like to write Leo and ask if he has any idea if Aspire is keeping any investment in CTIX (aside from the freebee shares, if that) It is needed funds, I don't see it as much of a positive if they simply sell each time. My biggest concern is that CTIX can not uplist without a RS. I think Leo and Dr. M are as much disheartened by the lack of market buying response to the last PRs and they might have to reconsider a RS which is a game changer for me if they do. As far as the rest of 2013 goes, I hope for an upswing but at this point I'm expecIing CTIX to be down for the year 2013, who would have thought. I guess we should remind Leo he has only a short time left to have 'the best is to come' come true for stockholders.in 2013. Leo's best is to come proved out in other ways, but not in the ways many investors hope, Kevetrin results and Prurisol results and for once to have Allan Harris be right, $13.00 a share for 2013. I should of known his prediction would be the curse of death! His prediction of $350.00 a share for NNVC by 2014 is a little short for a stock in the mid 5's.